Marc Santoro

Title: The Innovative Contributions of Marc Santoro

Introduction

Marc Santoro is a notable inventor based in Yardley, PA (US), recognized for his significant contributions to the field of biotechnology. With a total of five patents to his name, he has made strides in developing fully human antibodies that target human 4-1BB, a crucial component in immunotherapy.

Latest Patents

Santoro's latest patents focus on fully human antibodies against human 4-1BB. These antibodies and their antigen-binding portions are designed to bind to human 4-1BB, facilitating its interaction with the human 4-1BB ligand. Notably, one aspect of these antibodies is that they are classified as IgG4 antibodies. Additionally, the patents include methods for treating diseases in subjects by administering a therapeutically effective amount of these antibodies.

Career Highlights

Marc Santoro is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to improve therapeutic options for patients suffering from various diseases.

Collaborations

Santoro collaborates with esteemed colleagues, including Maria N Jure-Kunkel and Laura J Hefta, who contribute to the innovative projects at Bristol-Myers Squibb Company.

Conclusion

Marc Santoro's work exemplifies the impact of innovation in biotechnology, particularly in the development of therapeutic antibodies. His contributions are vital to the advancement of medical treatments and the improvement of patient outcomes.